TIAA CREF Investment Management’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

TIAA CREF Investment Management’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$72K	Buy	30,905 +1,741	+6%	+$4.72K	﹤0.01%	2979
2018 Q4	$68K	Sell	29,164 -624	-2%	-$5.5K	﹤0.01%	2986
2018 Q3	$441K	Sell	29,788 -4,242	-12%	-$67.4K	﹤0.01%	2769
2018 Q2	$517K	Buy	+34,030	New	+$578K	﹤0.01%	2773
2018 Q1	–	Sell	-7,433	Closed	-$135K	–	3085
2017 Q4	$135K	Sell	7,433 -813	-10%	-$17.2K	﹤0.01%	3024
2017 Q3	$183K	Buy	+8,246	New	+$181K	﹤0.01%	3049

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TIAA CREF Investment Management's SNNA Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Sienna Biopharmaceuticals, Inc. (SNNA) stake by 6% in Q1 2019, buying an estimated $4.72K and bringing the position to 30,905 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

TIAA CREF Investment Management first reported a position in SNNA in Q3 2017 and has held it in 6 quarters since. The position peaked at $517K in Q2 2018. 57 funds tracked by Wall St. Rank hold SNNA as of Q1 2019.

TIAA CREF Investment Management held 30,905 shares of Sienna Biopharmaceuticals, Inc. worth $72K as of Q1 2019.
TIAA CREF Investment Management bought 1,741 Sienna Biopharmaceuticals, Inc. shares in Q1 2019, an estimated $4.72K.
Sienna Biopharmaceuticals, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2979 holding.
TIAA CREF Investment Management first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and has held it in 6 quarters since.
TIAA CREF Investment Management's Sienna Biopharmaceuticals, Inc. position peaked at $517K in Q2 2018.
57 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.